HR. 1405In Committee
Enhancing Domestic Drug Manufacturing Competitiveness Act
Plain-English overview
What this bill does
Requires the Government Accountability Office to study regulatory barriers to domestic pharmaceutical manufacturing and report recommendations to improve U.S. competitiveness
Key points
- Require a GAO study
- Assess regulatory barriers
- Review supply chain impacts
- Recommend streamlining steps
Current status
Where it stands
Status
In Committee
Latest action
2025-02-18 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
Select a topic to continue exploring related legislation, members, and committees.
Discovery signals
About these signals
Impact and Momentum are relative discovery aids calculated by Legislation Lemur. They help you scan the congressional record; they are not predictions, endorsements, ideological ratings, or measures of policy importance.
Impact ScoreOverall observed legislative footprint and accumulated activity.
MomentumHow recently active or changing the bill appears in available data.